AT539170T - Assessment and reduction of the risk of graft-versus-host reaction - Google Patents

Assessment and reduction of the risk of graft-versus-host reaction

Info

Publication number
AT539170T
AT539170T AT07719640T AT07719640T AT539170T AT 539170 T AT539170 T AT 539170T AT 07719640 T AT07719640 T AT 07719640T AT 07719640 T AT07719640 T AT 07719640T AT 539170 T AT539170 T AT 539170T
Authority
AT
Austria
Prior art keywords
graft
assessment
versus
risk
reduction
Prior art date
Application number
AT07719640T
Other languages
German (de)
Inventor
Claude Perreault
Chantal Baron
Roland Somogyi
Larry Greller
Original Assignee
Univ Montreal
Biosystemix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US74576106P priority Critical
Application filed by Univ Montreal, Biosystemix Ltd filed Critical Univ Montreal
Priority to PCT/CA2007/000714 priority patent/WO2007124578A1/en
Publication of AT539170T publication Critical patent/AT539170T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • G01N2800/245Transplantation related diseases, e.g. graft versus host disease
AT07719640T 2006-04-27 2007-04-27 Assessment and reduction of the risk of graft-versus-host reaction AT539170T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US74576106P true 2006-04-27 2006-04-27
PCT/CA2007/000714 WO2007124578A1 (en) 2006-04-27 2007-04-27 Assessment and reduction of risk of graft-versus-host disease

Publications (1)

Publication Number Publication Date
AT539170T true AT539170T (en) 2012-01-15

Family

ID=38655008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07719640T AT539170T (en) 2006-04-27 2007-04-27 Assessment and reduction of the risk of graft-versus-host reaction

Country Status (6)

Country Link
US (4) US7763425B2 (en)
EP (1) EP2021534B1 (en)
JP (1) JP5171812B2 (en)
AT (1) AT539170T (en)
CA (1) CA2650507A1 (en)
WO (1) WO2007124578A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932808B1 (en) 2004-01-21 2015-01-13 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining a graft tolerant phenotype in a subject
USRE46843E1 (en) 2005-03-14 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
EP1869213A4 (en) 2005-03-14 2008-05-14 Univ Leland Stanford Junior Methods and compositions for evaluating graft survival in a solid organ transplant recipient
WO2009075811A1 (en) * 2007-12-07 2009-06-18 Tufts Medical Center, Inc. Compositions and methods for immortalizing cells and screening for anti-cancer agents
KR20100120657A (en) * 2008-01-22 2010-11-16 베리덱스, 엘엘씨 Molecular staging of stage ii and iii colon cancer and prognosis
US20110201519A1 (en) * 2008-08-18 2011-08-18 Sarwal Minnie M Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject
ES2492498T3 (en) 2009-01-15 2014-09-09 The Board Of Trustees Of The Leland Stanford Junior University Biomarker panel for the diagnosis and prediction of graft rejection
WO2010096160A1 (en) * 2009-02-17 2010-08-26 The Board Of Trustees Of The Leland Stanford Junior University Compartment-specific non-hla targets for diagnosis and prediction of graft outcome
GB0917457D0 (en) * 2009-10-06 2009-11-18 Glaxosmithkline Biolog Sa Method
WO2011068829A1 (en) 2009-12-02 2011-06-09 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for determining an allograft tolerant phenotype
IT1397083B1 (en) * 2009-12-04 2012-12-28 Biouniversa S R L Serum biochemical markers
EP2550371A4 (en) 2010-03-25 2013-11-20 Univ Leland Stanford Junior Protein and gene biomarkers for rejection of organ transplants
US20120277999A1 (en) * 2010-10-29 2012-11-01 Pbd Biodiagnostics, Llc Methods, kits and arrays for screening for, predicting and identifying donors for hematopoietic cell transplantation, and predicting risk of hematopoietic cell transplant (hct) to induce graft vs. host disease (gvhd)
CA2820134A1 (en) * 2010-12-06 2012-06-14 Dainippon Sumitomo Pharma Co., Ltd. Human monoclonal antibody
US8440797B2 (en) 2010-12-06 2013-05-14 Dainippon Sumitomo Pharma Co., Ltd. Human monoclonal antibody
GB201021149D0 (en) * 2010-12-14 2011-01-26 Georg August Uni Gottingen Stiftung Offentlichen Rechts Use of a skin explant assay for mRNA expression analysis for the identification of new genes and drug targets associated with graft versus host disease
US8962261B2 (en) 2011-04-06 2015-02-24 The Board Of Trustees Of The Leland Stanford Junior University Autoantibody biomarkers for IGA nephropathy
JP5904801B2 (en) * 2012-01-17 2016-04-20 シスメックス株式会社 Biomarkers for use in the prediction method and a method of inducing the differentiation into regulatory t cells, as well as their use
US20150275301A1 (en) * 2012-10-05 2015-10-01 Hitachi Chemical Co., Ltd. URINE EXOSOME mRNAS AND METHODS OF USING SAME TO DETECT DIABETIC NEPHROPATHY
US20160169890A1 (en) * 2013-05-20 2016-06-16 The Trustees Of Columbia University In The City Of New York Tracking donor-reactive tcr as a biomarker in transplantation
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
US9563744B1 (en) * 2014-12-03 2017-02-07 Biodesix, Inc. Method of predicting development and severity of graft-versus-host disease
CN104878099B (en) * 2015-05-15 2018-02-16 西北农林科技大学 Goat atbf1 gene single nucleotide polymorphism detection method and its application
WO2019014667A1 (en) * 2017-07-14 2019-01-17 The Regents Of The University Of California Novel methods of predicting transplant rejection risk

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
EP1334113A4 (en) 2000-10-20 2007-08-08 Expression Diagnostics Inc Leukocyte expression profiling
JP2005536212A (en) * 2002-08-22 2005-12-02 ノバルティス アクチエンゲゼルシャフト Diagnosis of chronic rejection
US20070111210A1 (en) * 2003-12-03 2007-05-17 Marc Bigaud Biomarkers for graft rejection
WO2005074540A2 (en) 2004-01-30 2005-08-18 University Of Pennsylvania Novel predictors of transplant rejection determined by peripheral blood gene-expression profiling

Also Published As

Publication number Publication date
US7763425B2 (en) 2010-07-27
US20100248254A1 (en) 2010-09-30
US9102981B2 (en) 2015-08-11
US20150337374A1 (en) 2015-11-26
US20130324427A1 (en) 2013-12-05
CA2650507A1 (en) 2007-11-08
EP2021534A1 (en) 2009-02-11
JP2009538599A (en) 2009-11-12
JP5171812B2 (en) 2013-03-27
US20070264272A1 (en) 2007-11-15
EP2021534B1 (en) 2011-12-28
EP2021534A4 (en) 2009-11-11
WO2007124578A1 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
AT462357T (en) Mts-instrument assembly for minimal incision and the maximum approach to the spine
DE602005008209D1 (en) Keyboard and keyboard arrangement
AT514776T (en) Aptamer-regulated nucleic acids and uses thereof
AT543825T (en) Spiro-oxindole compounds and their uses as therapeutic agents
AT528024T (en) Tendon or bänderbioprothesen and manufacturing processes for
DE602006019631D1 (en) Functional liquid and the manufacturing processes for
DE602007009990D1 (en) Sehachsenrichtungs-proof device and sehlinienrichtungs-detection methods
DE602007010580D1 (en) Inzisionsinstrument, lancing and block
AT432955T (en) Polyglutamate-amino acid-conjugates and methods
AT543835T (en) Anti-CD79b-antibody and immunoconjugates and application procedures
DE602006004792D1 (en) Potenzreihenvorverzerrer and control methods
AT530630T (en) Liquid treatment composition
AT487020T (en) Hybridbohrmeissel and drilling procedure
AT551421T (en) Rnai modulation of RSV and their therapeutic uses
DE602006013492D1 (en) Processes and Intermediates
AT469144T (en) pyridone substituted and application procedures
AT547513T (en) Ketoreductase polypeptides and uses thereof
AT553285T (en) Doppelhubkipphebelarmverriegelungsmechanismus and activity arrangement for
AT526882T (en) Combined photoacoustic and ultrasound-representation system
AT419282T (en) Catalyst composition and use thereof
DE602007002740D1 (en) Trocar and treatment system
DE602007006286D1 (en) Ystem and procedures
DE602007007386D1 (en) Distalend endoscope cover and provided therewith endoscope
AT545131T (en) Tonkodierungsvorrichtung and tonkodierungsmethode
AT527063T (en) Coating process and related coating device